Tadora is a medication classified as a phosphodiesterase type 5 inhibitor. It is primarily prescribed for the treatment of erectile dysfunction and pulmonary arterial hypertension. The drug works by blocking the enzyme that degrades cyclic guanosine monophosphate in smooth muscle cells. This inhibition leads to accumulation of cyclic guanosine monophosphate, causing relaxation of vascular smooth muscle. The resulting vasodilation improves blood flow to the genital region and to the lungs, respectively. In erectile dysfunction the enhanced blood flow facilitates the attainment and maintenance of an erection. In pulmonary arterial hypertension the increased pulmonary blood flow reduces arterial pressure and alleviates symptoms.

Tadora is a medication that enhances smooth muscle relaxation to improve blood flow. Its active ingredient works by targeting specific enzymes that regulate vascular tone. By inhibiting these enzymes it promotes the production of a signaling molecule that relaxes blood vessels. This physiological effect supports the treatment of certain cardiovascular conditions. The drug mechanism involves selective modulation of cellular pathways that lead to vasodilation. Overall Tadora provides therapeutic benefit through controlled vascular response.

Headache may occur due to increased blood flow to the brain. Dizziness or light-headedness can be experienced, especially when standing quickly. Flushing and warmth in the face or neck are common reactions. Mild stomach discomfort or indigestion may appear after taking the medication. Muscle aches, particularly in the back or limbs, have been reported. Nasal congestion or a runny nose can also develop as a side effect.

Tadora may cause mild fatigue in some individuals. Headaches have been reported after taking higher doses. Dizziness can occur especially when standing up quickly. Digestive discomfort such as nausea may appear. Some users experience a temporary drop in blood pressure. Insomnia or difficulty sleeping has been noted in rare cases. These effects usually subside as the body adjusts.